Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy

Basic Research in Cardiology

Volumn 108, Issue 4, 2013, Pages

  Haghikia, A ^a   Podewski, E ^a   Libhaber, E ^b,c   Labidi, S ^a   Fischer, D ^a   Roentgen, P ^a   Tsikas, D ^a   Jordan, J ^a   Lichtinghagen, R ^a   Von Kaisenberg, C S ^a   Struman, I ^d   Bovy, N ^d   Sliwa, K ^b   Bauersachs, J ^a   Hilfiker Kleiner, Denise ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Biomarker; MicroRNA; Peripartum cardiomyopathy; Prolactin; Registry

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BROMOCRIPTINE; CANDESARTAN; CARVEDILOL; CATHEPSIN D; DIGITOXIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; EPLERENONE; ESMOLOL; IRBESARTAN; LISINOPRIL; LOOP DIURETIC AGENT; METOPROLOL; MICRORNA 146A; N(G),N(G) DIMETHYLARGININE; PROLACTIN; RAMIPRIL; SPIRONOLACTONE; TELMISARTAN; THIAZIDE DIURETIC AGENT; VALSARTAN;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOMYOPATHY; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GERMANY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MORTALITY; PERIPARTUM CARDIOMYOPATHY; PHENOTYPE; PROGNOSIS;

EID: 84879387544     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0366-9     Document Type: Article

References (26)

1. Anderssohn M, Rosenberg M, Schwedhelm E, Zugck C, Lutz M, Luneburg N, Frey N, Boger RH (2012) The l-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy. J Card Fail 18:904-911. doi: 10.1016/j.cardfail.2012.10.011
2. Blauwet LA, Cooper LT (2011) Diagnosis and management of peripartum cardiomyopathy. Heart 97:1970-1981. doi: 10.1136/heartjnl-2011-300349
3. Elkayam U (2011) Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 58:659-670. doi: 10.1016/j.jacc.2011.03.047
4. Fett JD (2002) Peripartum cardiomyopathy. Insights from Haiti regarding a disease of unknown etiology. Minn Med 85:46-48
5. Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, Becker A, Yip A, Klein G, Sliwa K (2008) Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail 10:861-868. doi: 10.1016/j.ejheart.2008.07.005
6. Goland S, Bitar F, Modi K, Safirstein J, Ro A, Mirocha J, Khatri N, Elkayam U (2011) Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail 17:426-430. doi: 10.1016/j.cardfail.2011.01.007
7. Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, Illum S, Hatamizadeh P, Elkayam U (2009) Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 15:645-650. doi: 10.1016/j.cardfail. 2009.03.008
8. Haghikia A, Missol-Kolka E, Tsikas D, Venturini L, Brundiers S, Castoldi M, Muckenthaler MU, Eder M, Stapel B, Thum T, Petrasch-Parwez E, Drexler H, Hilfiker-Kleiner D, Scherr M (2011) Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. Eur Heart J 32:1287-1297. doi: 10.1093/eurheartj/ehq369
9. Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, Scherr M, Castermans K, Malvaux L, Lambert V, Thiry M, Sliwa K, Noel A, Martial JA, Hilfiker-Kleiner D, Struman I (2013) MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 123:2143-2154. doi: 10.1172/jci64365
10. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H (2007) A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589-600. doi: 10.1016/j.cell.2006.12.036 (Pubitemid 46206082)
11. Hilfiker-Kleiner D, Meyer GP, Schieffer E, Goldmann B, Podewski E, Struman I, Fischer P, Drexler H (2007) Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol 50:2354-2355. doi: 10.1016/j.jacc.2007.10.006 (Pubitemid 350192108)
12. Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, Ikeda T (2011) Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J 75:1975-1981. (pii: JST.JSTAGE/circj/CJ-10-1214)
13. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the D, Treatment of A, Chronic Heart Failure of the European Society of C, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, Guidelines ESCCfP (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803-869. doi: 10.1093/eurjhf/hfs105
14. Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, Hershberger RE (2010) Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 121:2176-2182. doi: 10.1161/CIRCULATIONAHA.109. 931220
15. Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z (2012) Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485:333-338. doi: 10.1038/nature11040
16. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL (2000) Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA, J Am Med Assoc 283:1183-1188. doi: 10.1001/jama.283.9.1183 (Pubitemid 30126607)
17. Ross RM, Baker T (1995) Cardiac enzymes in patients undergoing caesarean section. Can J Anaesth 42:46-50. doi: 10.1007/BF03010571
18. Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH (2003) Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361:1511-1517 (Pubitemid 36566342)
19. Selle T, Renger I, Labidi S, Bultmann I, Hilfiker-Kleiner D (2009) Reviewing peripartum cardiomyopathy: current state of knowledge. Future Cardiol 5:175-189. doi: 10.2217/14796678.5.2.175
20. Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, McMurray J, Yamac H, Labidi S, Struman I, Hilfiker-Kleiner D (2010) Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121:1465-1473. doi: 10.1161/CIRCULATIONAHA.109.901496
21. Sliwa K, Fett J, Elkayam U (2006) Peripartum cardiomyopathy. Lancet 368:687-693. doi: 10.1016/S0140-6736(06)69253-2 (Pubitemid 44223695)
22. Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, Ansari AA (2006) Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27:441-446. doi: 10.1093/eurheartj/ehi481 (Pubitemid 43209169)
23. Sliwa K, Forster O, Tibazarwa K, Libhaber E, Becker A, Yip A, Hilfiker-Kleiner D (2009) Long-term outcome of peripartum cardiomyopathy in a population with high seropositivity for human immunodeficiency virus. Int J Cardiol 147:202-208. doi: 10.1016/j.ijcard.2009.08.022
24. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12:767-778. doi: 10.1093/eurjhf/hfq120
25. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, Dooijes D, van den Berg MP (2010) Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 121:2169-2175
26. Walenta K, Schwarz V, Schirmer SH, Kindermann I, Friedrich EB, Solomayer EF, Sliwa K, Labidi S, Hilfiker-Kleiner D, Bohm M (2012) Circulating microparticles as indicators of peripartum cardiomyopathy. Eur Heart J 33:1469-1479